Company: BDRX
Filing Date: 2025-01-08
Form Type: 424B3
Source: 0001214659-25-000304
Chunk: 25

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-08
Form: 424B3
Chunk 25
---
 newspaper advertisements 
 are met) and prior to the sale the Company has not received any communication (whether in writing or otherwise) in respect of such share        
 from the member or person entitled by transmission; and                                                                                         |

| (E) | if such share is listed or dealt in on any stock exchange, the Company has first given notice in writing 
 to that exchange (where required) of its intention to sell such share.                                   |

| 31.2 | If during such twelve (12) year period, or during any subsequent period ending on the date when all the                                      
 requirements of Article 31.1 have been met in respect of any shares, any additional shares that have been issued in respect of those held    
 at the beginning of, or previously so issued during, any such subsequent period and all the requirements of Article 31.1 have been satisfied 
 with regard to such additional shares, the Company may also sell the additional shares.                                                      |

| 31.3 | To give effect to a sale pursuant to Article 31.1 or Article 31.2, the Board may: |

| (A) | in the case of certificated shares, authorise a person to execute an instrument of transfer of shares                                        
 in the name and on behalf of the holder of, or the person entitled by transmission to, them to the purchaser or as the purchaser may direct; 
 and                                                                                                                                          |

| (B) | in the case of uncertificated shares, exercise any power conferred on it by Article 15.10 (uncertificated 
 shares) to effect a transfer of the shares.                                                               |

| 31.4 | The purchaser will not be bound to see to the application of the purchase monies in respect of any such                                   
 sale, nor will its title to the shares be affected by any irregularity in or invalidity of the proceedings connected with the sale or     
 transfer. Any instrument or exercise referred to in Article 31.3 shall be effective as if it had been executed or exercised by the holder 
 of, or the person entitled by transmission to, the shares to which it relates.                                                            |

| 32 | APPLICATION OF SALE PROCEEDS |

The Company shall account to the member
or other person entitled to such share for the net proceeds of such sale by carrying all monies in respect of the sale to a separate account.
The Company shall be deemed to be a debtor to, and not a trustee for, such member or other person in respect of such monies